Struggling biotech’s revenue and profit plunged. Wall Street saw something to cheer.
Washington Post
Novavax’s stock surged 30 percent Tuesday, it’s biggest one-day gain in more than two years as the struggling vaccine maker pledged to slash costs and disclosed promising results of vaccines in development.
https://www.washingtonpost.com/business/2023/05/09/novavax-covid-vaccine-stock-price/